Global, regional, and national burden and trends of pancreatic cancer, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
Frontiers in Oncology · 03.11.2025 · 15
DOI: 10.3389/fonc.2025.1671856 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Oncology, online erschienen am 03.11.2025. Verfasst von Chunlong Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary and Pancreatic Surgery, Fuyang People's Hospital, Anhui Medical University, Fuyang, China. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
To evaluate temporal trends, associated risk factors, and cross-national inequalities in the distribution of pancreatic cancer from 1990 to 2021.
Methods
Temporal trends were measured using the average annual percent change and annual percent change. A comparative risk assessment framework was employed to estimate the proportion of disability-adjusted life years (DALYs) attributable to specific risk factors for pancreatic cancer. In addition, the unequal distribution of the global burden of pancreatic cancer was quantified using the inequality slope index and the concentration index, as recommended by the World Health Organization.
Results
From 1990 to 2021, the global incidence, prevalence, mortality and DALYs associated with pancreatic cancer have increased in absolute numbers. At the regional level, Central Asia recorded the highest values for all four indicators, while Western Sub-Saharan Africa experienced the most pronounced escalation in disease burden. Notably, the burden of pancreatic cancer was consistently higher in males than in females throughout the study period. Cross-national inequalities analysis reveals that disparities in pancreatic cancer burden are concentrated in countries with relatively higher socio-demographic index. To date, the high fasting plasma glucose remained the major risk factor that influenced the DALYs of pancreatic cancer, followed by smoking and high body mass index.
Conclusion
The global burden of pancreatic cancer is rising, particularly among males and in high-income regions. This trend highlights the urgent need for targeted prevention strategies and improved management of modifiable risk factors, with a specific focus on these high-risk populations.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hepatobiliary and Pancreatic Surgery, Fuyang People's Hospital, Anhui Medical University, Fuyang, China.
- Department of Hepatobiliary and Pancreatic Surgery, Fuyang People's Hospital, Bengbu Medical University, Fuyang, China.
Zitieren
APA
Liu, C., Liu, P., Liu, X., Niu, W., Wu, P., & Yu, J. (2025). Global, regional, and national burden and trends of pancreatic cancer, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. Frontiers in Oncology, 15. https://doi.org/10.3389/fonc.2025.1671856
Vancouver
Liu C, Liu P, Liu X, Niu W, Wu P, Yu J. Global, regional, and national burden and trends of pancreatic cancer, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. Frontiers in Oncology. 2025;15. doi:10.3389/fonc.2025.1671856
BibTeX
@article{Liu2025,
author = {Liu, Chunlong and Liu, Pengpeng and Liu, Xue and Niu, Wang and Wu, Panpan and Yu, Jiangtao},
title = {Global, regional, and national burden and trends of pancreatic cancer, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021},
journal = {Frontiers in Oncology},
year = {2025},
volume = {15},
doi = {10.3389/fonc.2025.1671856}
}
EUVIMED